Healthy Offspring in Parents Both Receiving Thiopurines [5]

Gastroenterology

Volumn 126, Issue 2, 2004, Pages 628-

  Oefferlbauer Ernst, Anna ^a   Reinisch, Walter ^a   Miehsler, Wolfgang ^a   Vogelsang, Harald ^a   Dejaco, Clemens ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE;

ADULT; CASE REPORT; CLINICAL FEATURE; CONCEPTION; CROHN DISEASE; DISEASE COURSE; DRUG SAFETY; FEMALE; HEALTH STATUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MALE; PARENT; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; TREATMENT OUTCOME;

EID: 0842300372     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2003.12.030     Document Type: Letter

References (4)

1. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology 2003;124:9-17.
2. Rajapakse RO, Korelitz BI, Zlatanic J, Baiocco PJ, Gleim GW. Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol 2000;95:684-688.
3. Ben-Neriah Z, Ackerman Z. WAGR syndrome in a baby-the result of 6-MP treatment in a father affected by Crohn's disease? Am J Gastroenterol 2001;96:251.
4. Dejaco C, Mittermaier C, Reinisch W, Gasche C, Waldhoer T, Strohmer H, Moser G. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001;121: 1048-1053.